Breaking News
April 19, 2019 - Key research takeaways from ECCMID 2019
April 19, 2019 - AI Can Identify Model of Cardiac Rhythm Device From Chest X-Ray
April 19, 2019 - New way to combat childhood anxiety: treat the parents
April 19, 2019 - Women getting C-sections best judge of own pain medication needs | News Center
April 19, 2019 - Immune responses that prevent fungal infections may eliminate Trichinella spiralis
April 19, 2019 - Exercising in the morning, rather than at night, may yield better results, shows study
April 19, 2019 - Why eating ‘right’ could cause you to stray from your diet
April 19, 2019 - Health Tip: Antidepressant Precautions – Drugs.com MedNews
April 19, 2019 - Bigger portions lead to preschoolers eating more over time
April 19, 2019 - Specific strains of Staphylococcus aureus linked to wounds that do not heal
April 19, 2019 - Revolutionary discovery paves new way for treatment of necrotizing enterocolitis
April 19, 2019 - Drug that treats high blood pressure shows promise against neurodegenerative diseases
April 19, 2019 - More care is needed for patients after kidney transplantations, reports research
April 19, 2019 - Virtual reality offers benefits for Parkinson’s disease patients
April 19, 2019 - Liver Illness Strikes Latino Children Like A ‘Silent Tsunami’
April 19, 2019 - Disruptive behaviors in autistic children linked to reduced brain connectivity
April 19, 2019 - New insights into how vitamin D affects immune system
April 19, 2019 - Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older
April 19, 2019 - Exercise can improve non-motor symptoms of Parkinson’s disease
April 19, 2019 - KZFPs play a key role in the regulation of human genome
April 19, 2019 - Extracts of ginkgo seeds show antibacterial activity on pathogens that cause skin infections
April 19, 2019 - Groundbreaking experiment in pigs challenges the notion about brain damage
April 19, 2019 - Improving the quality of digital pathology imaging
April 19, 2019 - Scientists get closer to injecting artificial lymph nodes into people to fight disease
April 19, 2019 - Exercises and swimming goggles may reduce adverse effects on eye during long spaceflights
April 19, 2019 - Review suggests a reciprocal relationship between obesity and self-control
April 19, 2019 - Study identifies how enterococci bacteria cause antibiotic-resistant bloodstream infections
April 19, 2019 - Triple negative breast cancer develop resistance to chemotherapy by turning on molecular pathway
April 19, 2019 - Researchers identify key clues to brain and pancreas development
April 19, 2019 - Metformin May Cut Risk for Prematurity, Miscarriage in PCOS
April 19, 2019 - Obese mouse mothers trigger heart problems in offspring
April 19, 2019 - Research sheds light on how leukemia cells become resistant to drugs
April 19, 2019 - Health Tip: Stopping Nosebleeds – Drugs.com MedNews
April 19, 2019 - Pediatric endocrinologist gives iconic ‘Mona Lisa’ a second medical opinion
April 19, 2019 - Tapping patients’ wisdom for C-section pain management
April 18, 2019 - Why have autism rates ‘exploded’ in New Jersey?
April 18, 2019 - Microbiome science may help doctors to improve treatment for children with IBS
April 18, 2019 - New gene therapy cures babies with fatal ‘Bubble Boy’ disease
April 18, 2019 - No female mice? Scientists may still approve NIH grant
April 18, 2019 - What needs to be said about mental health in medicine
April 18, 2019 - Hickenlooper Expanded Medicaid, Created State-Run Marketplace To Insure Nearly All Coloradans
April 18, 2019 - Cancer cells grown in tumor-mimicking environment can help predict the effect of experimental drugs
April 18, 2019 - Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
April 18, 2019 - Adhesive gel bonds to eye surface, could repair injuries without surgery
April 18, 2019 - The future of genomics: A podcast featuring Stanford geneticists
April 18, 2019 - As Syphilis Invades Rural America, A Fraying Health Safety Net Is Failing To Stop It
April 18, 2019 - APOE gene impacts sleep depending on gender and severity of Alzheimer’s
April 18, 2019 - PCORI’s newly approved awards focus on cancer pain and opioid use disorders
April 18, 2019 - New tool provides a standard way to measure effects of caring for survivors of TBI
April 18, 2019 - Smartphone use risks eye examination misdiagnosis
April 18, 2019 - How drug-resistant bugs grow in CF patients’ lungs
April 18, 2019 - Gordana Vunjak-Novakovic Elected to American Academy of Arts & Sciences
April 18, 2019 - Podcast: KHN’s ‘What The Health?’ You Have Questions, We Have Answers
April 18, 2019 - Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients
April 18, 2019 - New estimation method assesses natural variations in sex ratio at birth
April 18, 2019 - UTA scientist receives $1.17 million grant for cancer research
April 18, 2019 - Coagulation factor VIIa prevents bleeds in hemophilia animal models
April 18, 2019 - Researchers identify risk factors for severe infection after knee replacement
April 18, 2019 - Mass drug administration can offer community-level protection against malaria
April 18, 2019 - FDA’s added sugar label could have substantial health and cost-saving benefits
April 18, 2019 - Researchers identify cause of inherited metabolic disorder
April 18, 2019 - Single strip of white paint not sufficient to protect people who ride bikes
April 18, 2019 - Partner status influences link between sexual problems and self-efficacy in breast cancer survivors
April 18, 2019 - Colorectal Neoplasia Risk Up for Hodgkin Lymphoma Survivors
April 18, 2019 - Rigid spine muscular dystrophy – Genetics Home Reference
April 18, 2019 - Simple bile acid blood test could tell risk of stillbirth
April 18, 2019 - Center for Experimental Therapeutics aims to enable all steps of drug development | News Center
April 18, 2019 - Falling for telephone scams could be an early sign of dementia
April 18, 2019 - Researchers annotate key neuronal proteins in lamprey genome
April 18, 2019 - Study uncovers new biomarker for personalized cancer treatments
April 18, 2019 - Scientists enter research collaboration to find a cure for cancer
April 18, 2019 - Study to compare benefits of tai chi and mindfulness meditation on MS symptoms
April 18, 2019 - Gestational diabetes during pregnancy may increase risk of type 1 diabetes in children
April 18, 2019 - Maternal age has no effect on IVF success, conclude researchers
April 18, 2019 - Is a New Remedy for Body Odor on the Horizon?
April 18, 2019 - Orthostatic hypotension – Genetics Home Reference
April 18, 2019 - Healing the heartbreak of stillbirth and newborn death
April 18, 2019 - New study calls healthiness of eggs into question
April 18, 2019 - Conference to highlight advances in human immune monitoring, bioinformatics | News Center
April 18, 2019 - Bacteria use viruses for self-recognition, study reveals
Low BP Associated With Risk in HFpEF

Low BP Associated With Risk in HFpEF

image_pdfDownload PDFimage_print

Action Points

  • Note that this analysis of registry data suggests an association between discharge with lower blood pressure and all-cause mortality among those with heart failure with preserved ejection fraction.
  • Be aware that the diagnosis of HFPEF may not represent a homogeneous clinical entity.

In hospitalized older people with heart failure with preserved ejection fraction (HFpEF), a systolic blood pressure level less than 120 mm Hg is independently associated with mortality and readmissions, according to a large observational study.

Systolic pressure under 120 mm Hg at discharge was associated with 2.07-fold risk (95% CI 1.45-2.95, P<0.001) of all-cause mortality within 30 days compared with higher blood pressure in matched patients, Ali Ahmed, MD, MPH, of the Veterans Affairs Medical Center in Washington, D.C., and colleagues reported online in JAMA Cardiology.

Systolic blood pressure (SBP) less than 120 mm Hg was also associated with a higher risk of mortality at 1 year (HR 1.36, 95% CI 1.16-1.59, P<0.001) and across the average follow-up of 2.1 years (HR 1.17, 95% CI 1.05-1.30, P=0.005).

A higher risk of heart failure readmission was also noted at 30 days (HR 1.47, 95% CI 1.08-2.01, P=0.02) but not at 1 year or the overall up to 6 years of follow-up. Hazard ratios for the combined endpoint of heart failure readmission or all-cause mortality associated with a low systolic level less than 120 mm Hg were:

  • At 30 days, 1.71 (95% CI 1.34-2.18 P<0.001)
  • At 1 year, 1.21 (95% CI 1.07-1.38 P=0.004)
  • Overall, 1.12 (95% CI 1.01-1.24 P=0.03)

Notably, “this association was essentially unchanged when lower SBP was defined as SBP levels less than 130 mm Hg. An SBP level less than 120 mm Hg was also associated with a significantly higher risk of the combined endpoints of heart failure readmission or mortality at all 3 times,” they wrote.

The study found no evidence of a nonlinear association between SBP and all cause mortality (P>0.20), they noted. “The association between SBP levels less than 120 mm Hg and overall all-cause mortality in our matched cohort was homogenous across various clinically relevant subgroups of patients, except those with a glomerular filtration rate less than 45 mL/min/1.73m2 and those who received a discharge prescription for ACE inhibitors.”

National guidelines for HF recommend that SBP levels should be controlled in patients with heart failure with preserved ejection fraction (HFpEF) in general, and the new 2017 blood pressure guidelines suggest an optimal target level of less than 130 mm Hg in patients with HFpEF and persistent hypertension. However, “an optimal SBP target level is less clear for patients with HFpEF,” the group noted.

“These recommendations are extrapolated from populations without heart failure because direct evidence from patients with HFpEF is limited,” they opined. “The ACE inhibitors and angiotensin II receptor blockers have been shown to modestly lower SBP levels in patients with HFpEF, but this did not translate into better outcomes.”

Ahmed’s group suggested that this and other observational studies linking lower SBP level with poor outcomes in HF patients may reflect the poorly understood phenomenon of reverse epidemiology. “Future prospective randomized clinical trials need to examine the effect of various SBP target levels on outcomes in patients with HFpEF.”

The study assessed data from the Medicare-linked Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) registry, which included more than 25,000 patients hospitalized nationwide between March 1, 2003, and Dec. 31, 2004.

Among them, 35% had an ejection fraction of at least 50%. Analysis was restricted to include the 44% of those low ejection fraction patients with stable inpatient SBP levels that varied 20 mm Hg or less from admission to discharge.

Of this cohort of almost 4,000 patients, 27% had SBP levels less than 120 mm Hg. The main analyses were on a group of 1,802 patients with higher or lower SBP who were propensity score matched on 58 baseline characteristics.

Limitations include the study’s observational nature, its potential for bias due to unmeasured confounders, and unknown generalizability to ambulatory patients with HFpEF because of differences in blood pressure determinants and measurement by setting.

While the study raised some interesting hypotheses, Willie Lawrence, MD, of the Research Medical Center in Kansas City, Missouri, echoed authors’ observations regarding the study’s lack of generalizability. He cautioned that randomized double blind studies are needed, noting that studies like SPRINT and ACCORD provide a strong basis for guideline recommendations.

As well, he noted many confounders: The diagnosis of heart failure with preserved ejection fraction is “a hodge podge of diagnoses that might include renal failure, chronic lung disease, or diastolic dysfunction for instance; heart failure is treated differently now than it was at the time of this study.”

The Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) was sponsored by GlaxoSmithKline.

Ahmed was supported by the National Institutes of Health grants from the National Heart, Lung, and Blood Institute.

Several authors disclosed relevant relationships with industry.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

1969-12-31T19:00:00-0500

last updated

Tagged with:

About author

Related Articles